Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases

BACKGROUND: The COVID-19 vaccines are currently recommended for people with rare neuroimmunological diseases such as neuromyelitis optica spectrum disorder (NMOSD), MOG-antibody disease (MOGAD), and transverse myelitis. However, the safety profile of the vaccines in this population is uncertain. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotan, Itay, Romanow, Gabriela, Levy, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327627/
https://www.ncbi.nlm.nih.gov/pubmed/34375861
http://dx.doi.org/10.1016/j.msard.2021.103189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327627/
https://www.ncbi.nlm.nih.gov/pubmed/34375861
http://dx.doi.org/10.1016/j.msard.2021.103189

Ejemplares similares